Navigation Links
Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008
Date:5/15/2008

LAIYANG, China, May 15 /Xinhua-PRNewswire-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GTEC) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced its financial results for the quarter ended March 31, 2008, the Company's third quarter of its fiscal year ended June 30, 2008. A 10QSB Form was filed for the quarter with the U.S. Securities Exchange Commission that is available through the Company's website and from the SEC.

Third Quarter 2008 Highlights:

-- Revenue totaled $28.1 million, up 48.5% year-over-year

-- Gross profit totaled $21.8 million, up 60.7% year-over-year

-- Gross margin was 77.4%, compared to 71.5% a year ago

-- Net income rose to $4.5 million, up 138.46% from the quarter ended

March 31, 2007, $0.01 per basic and diluted share

-- Engaged Moore Stephens Wurth Frazer & Torbet, LLP as independent

auditor

"We are pleased to report financial results that confirm the growing popularity of our products. Our best selling products continue to be Clarithromycin sustained-release tablets and Itopride Hydrochloride granules. Sales for Baobaole chewable tablets, our first Chinese herbal over the counter drug product, have grown rapidly since we introduced it at the end of 2007," said Mr. Cao Wubo, Chairman and CEO of Genesis Pharmaceuticals Enterprises, Inc. "We have several new drugs that are still in various stages of approval from China's State Food and Drug Administration, and we believe that we will be able to introduce four new drugs in the near future."

Third Quarter of Fiscal Year 2008 Results

Total revenue in the third quarter ended March 31, 2008 was $28.1 million, up 48.5% from $18.9 million in the prior year's period. This increase in revenue was mostly due to increased sales of the Company's two most popular products, Clarithromycin sustained-rel
'/>"/>

SOURCE Genesis Pharmaceuticals Enterprises, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Cardiogenesis Reports First Quarter 2008 Results
2. Effect of mutant p53 stability on tumorigenesis and drug design
3. Cardiogenesis Corporation to Report 2008 First Quarter Results on May 15th
4. A stem cell type supposed to be crucial for angiogenesis and cancer growth does not exist?
5. Mitochondria play role in pathogenesis of AD and estrogen-induced neuroprotection
6. Science of Sri Vidya Benefits DNA Genesis, Says Dr. Sunita Rana Agarwal
7. Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs
8. Genesis Pharmaceuticals Changes Auditors
9. Cardiogenesis Corporation Announces Rescheduled Fourth Quarter and Full Year 2007 Earnings Release
10. Cardiogenesis Corporation Reports Delay in Earnings Release and Conference Call
11. Cardiogenesis Corporation to Report 2007 Fourth Quarter and Year-End Results on March 4th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , ... July 07, 2015 , ... Difass USA, a ... help pass those long, stressful days at work is knowing that there is hopefully ... laid back and stress free as imagined. Planning for a vacation can be quite ...
(Date:7/7/2015)... Angeles, CA (PRWEB) , ... July 07, 2015 ... ... International Business Times highlights rumors about possible facial rejuvenation that have emerged about ... year-old former U.S. Secretary of State looks more youthful than she has in ...
(Date:7/7/2015)... ... July 07, 2015 , ... Greatist today announced the ... helps active people find the most fun activities to do with friends. , The ... It also increases Greatist’s opportunity for events, e-commerce, and brand partnerships. , “I’ve been ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... only industry group whose board is limited to permit holders. The Medical Cannabis ... how to move the industry forward and are committed to making sure patients ...
(Date:7/7/2015)... ... July 07, 2015 , ... At the end of June Pacific Prime Renewals team in Hong ... This initiative, spearheaded by the Renewals Manager, Danielle Cotton, aims to not only reduce but ... this initiative Cotton explained, “We send anything between 300 and 600 pieces of paper per ...
Breaking Medicine News(10 mins):Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2
... prepare for a day without cigarettes and tobacco products ... Smokeout (R) (November 21), new research gives them more ... to the American Academy of Otolaryngology-Head and Neck Surgery ... organization,s annual meeting in September 2008 are studies that ...
... Nelson, PhD, served as vice-chair of the advisory committee ... by the U.S. Department of Health and Human Services ... for Physical Activity and Nutrition and Associate Professor of ... Policy at Tufts. , "After reviewing a ...
... A further new multidisciplinary journal in the neurosciences, ... March 2009. With this addition to its publishing ... of research, current practices and future trends in the ... the gap between the life sciences, social sciences, engineering, ...
... Institute have found that reducing the levels of vascular endothelial ... of new blood vessel growth, in adult mice causes the ... retina that are essential to visual function. This finding, published ... implications for the chronic use of promising new anti-VEGF drugs ...
... WOBURN, Mass., Nov. 3 Culbert Healthcare,Solutions, ... services firm, announced today that Norm Botsford ... the Strategic Services practice., Mr. Botsford ... Officer,at University Physicians Healthcare (UPH), the health ...
... Scientists at Schepens Eye Research,Institute have found that reducing ... best known as a stimulator of new blood,vessel growth, ... Muller,glia -- cells of the retina that are essential ... 2008 PLoS ONE, holds implications for,the chronic use of ...
Cached Medicine News:Health News:Smokers see decline in ability to smell, rise in laryngitis, and upper airway issues 2Health News:Tufts' Nelson a leader on Physical Activity Guidelines advisory committee 2Health News:Springer launches Cognitive Computation 2Health News:Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution 2Health News:Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution 3Health News:Norm Botsford Joins Culbert Healthcare Solutions' Strategic Services Team 2Health News:Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution 2Health News:Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution 3
(Date:7/7/2015)... -- Research and Markets ( ... "The New Trends of Global Preclinical Development ... The report, The New Trends of Global ... the current development states and the future growth ... The report is designed to reveal the latest ...
(Date:7/7/2015)... MILAN , July 7, 2015 /PRNewswire/ ... que la société P&R annonce l,acquisition de ... active au niveau mondial, spécialisée dans la ... à base d,acide hyaluronique.      ... est l,un des principaux groupes chimiques et ...
(Date:7/7/2015)... WASHINGTON , July 7, 2015 Noting ... and opaque" pricing policies currently practiced by the rapidly ... Pharmacy Coalition (SCPC) today praised Ohio ... into law a new state effort to help pull ... practices. "We applaud Governor Kasich for ...
Breaking Medicine Technology:New Trends in the 2015 Global Preclinical Development Outsourcing Market 2New Trends in the 2015 Global Preclinical Development Outsourcing Market 3New Trends in the 2015 Global Preclinical Development Outsourcing Market 4New Trends in the 2015 Global Preclinical Development Outsourcing Market 5National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 2National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 3
... 2011 A new report in the March issue of ... beat brand names when it comes to safety, efficacy, and ... drug programs offering these drugs at prices as low as ... Walgreens, and Walmart have been steadily expanding their discount programs, ...
... JumpStart Ventures , the non-profit that invests in ... Ohio, and Cleveland Clinic , announced a ... Inc. The Cleveland-based company is developing a topical ... formation in wounds. (Logo: http://photos.prnewswire.com/prnh/20060209/CLJUMPSTARTLOGO) ...
Cached Medicine Technology:Consumer Reports Health: Best Drugs for What Ails You, Plus Where to Buy Them for $4 a Month 2Consumer Reports Health: Best Drugs for What Ails You, Plus Where to Buy Them for $4 a Month 3Consumer Reports Health: Best Drugs for What Ails You, Plus Where to Buy Them for $4 a Month 4JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics 2JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics 3JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics 4
Albumin FS for determination of albumin in serum or plasma. For Hitachi 704 / 911. Available with Calibrator: Trucal U and Controls: Trulab N and Trulab P....
For the quantitative determination of Albumin in serum. Endpoint procedure with Amax at 630 nm. Linearity: to 6 g/dl. Liquid ready-to-use reagent....
ASAT (GOT) FS (IFCC mod). For determination of ASAT (GOT) in serum or plasma. For Hitachi 717. Controls: Trulab N and Trulab P....
AST (SGOT) reagent is used for the quantitative determination of aspartate aminotransferase (AST) in human serum....
Medicine Products: